$BKSY
BlackSky Technology Inc.

2018 Q4 Form 10-K Financial Statement

#000119312520065257 Filed on March 06, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q2 2018
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.180K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.180K
YoY Change
Operating Profit -$2.177K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.177K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$798.00 -$2.177K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$69.76
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q2 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.06K
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $42.06K $42.06K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $172.3K
YoY Change
Total Long-Term Assets $172.3K $172.3K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $42.06K $42.06K
Total Long-Term Assets $172.3K $172.3K
Total Assets $214.3K $214.3K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.490K
YoY Change
Accrued Expenses $1.488K $90.03K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $100.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $191.5K $191.5K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $191.5K $191.5K
Total Long-Term Liabilities $0.00
Total Liabilities $191.5K $191.5K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.177K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.82K $0.00 $22.82K
YoY Change
Total Liabilities & Shareholders Equity $214.3K $214.3K
YoY Change

Cashflow Statement

Concept 2018 Q4 2018 Q2 2018
OPERATING ACTIVITIES
Net Income -$798.00 -$2.177K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$689.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 42.75K
YoY Change
NET CHANGE
Cash From Operating Activities -689.0
Cash From Investing Activities
Cash From Financing Activities 42.75K
Net Change In Cash 42.06K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$689.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
202472
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1286083
CY2018Q4 us-gaap Assets
Assets
214338
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
181732
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42061
CY2018Q4 us-gaap Deferred Costs
DeferredCosts
172277
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1488
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1361
CY2018Q4 sftwu Accrued Offering Costs Current
AccruedOfferingCostsCurrent
90027
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
94636
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1237500
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Entity Registrant Name
EntityRegistrantName
Osprey Technology Acquisition Corp.
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001753539
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2019 dei Security12b Title
Security12bTitle
Common Stock
CY2019 dei Trading Symbol
TradingSymbol
SFTWU
CY2019 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019 dei Entity Shell Company
EntityShellCompany
true
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q4 us-gaap Cash
Cash
1083611
CY2018Q4 us-gaap Cash
Cash
42061
CY2019Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
316958514
CY2019Q4 us-gaap Assets
Assets
318245958
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
100000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
276368
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
191515
CY2019Q4 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11068750
CY2018Q4 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
0
CY2019Q4 us-gaap Liabilities
Liabilities
11345118
CY2018Q4 us-gaap Liabilities
Liabilities
191515
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
301900836
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4650349
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24051
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
348716
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2177
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
22823
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318245958
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214338
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
31625000
CY2019 sftwu Number Of Warrant Issued
NumberOfWarrantIssued
8325000
CY2019 sftwu Description Of Minimum Votes To Be Polled
DescriptionOfMinimumVotesToBePolled
These provisions of the Company’s Amended and Restated Certificate of Incorporation may only be amended if approved by holders of a majority of at least 90% of the Company’s common stock voting in a stockholder meeting.
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
30142702
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
264346
CY2018 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2177
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-264346
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-2177
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
714993
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6479
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
708514
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
444168
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2177
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93275
CY2019 us-gaap Net Income Loss
NetIncomeLoss
350893
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-2177
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7591097
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8250000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
474698
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1237500
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Net Income Loss
NetIncomeLoss
-2177
CY2019 sftwu Sale Of Units Net Of Underwriting Discounts And Value Offering Expenses
SaleOfUnitsNetOfUnderwritingDiscountsAndValueOfferingExpenses
298202124
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8325000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301900836
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
180244
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
94636
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2019 sftwu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
714993
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6479
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1488
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
94636
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1361
CY2019Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
1361
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-286574
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-689
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1361
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1361
CY2019 sftwu Payments For Investments Of Cash In Trust Account
PaymentsForInvestmentsOfCashInTrustAccount
316250000
CY2019 us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
The Sponsor and the Company’s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation (a) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
CY2019 sftwu Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
1.00
CY2019 sftwu Public Shares Redemption Percentage Threshold
PublicSharesRedemptionPercentageThreshold
0.15
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93275
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-316250000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of estimates </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019 sftwu Proceeds From Sale Of Units Net Of Underwriting Discounts
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscounts
309925000
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8325000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of credit risk </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
474698
CY2019 sftwu Net Loss Adjusted
NetLossAdjusted
-123805
CY2018 sftwu Net Loss Adjusted
NetLossAdjusted
-2177
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2019Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906250
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906250
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9487500
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9487500
CY2019 sftwu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
CY2019 sftwu Business Acquisition Percentage Of Minimum Ownership To Be Acquired
BusinessAcquisitionPercentageOfMinimumOwnershipToBeAcquired
0.50
CY2019Q2 dei Entity Public Float
EntityPublicFloat
0
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
124992
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1361
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
202472
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100000
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
224992
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
571876
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
82250
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
317578124
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42750
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1041550
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
42061
CY2019 sftwu Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
301534750
CY2019 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
366086
CY2018 sftwu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
90027
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
0

Files In Submission

Name View Source Status
0001193125-20-065257-index-headers.html Edgar Link pending
0001193125-20-065257-index.html Edgar Link pending
0001193125-20-065257.txt Edgar Link pending
0001193125-20-065257-xbrl.zip Edgar Link pending
d892225d10k.htm Edgar Link pending
d892225dex211.htm Edgar Link pending
d892225dex311.htm Edgar Link pending
d892225dex312.htm Edgar Link pending
d892225dex321.htm Edgar Link pending
d892225dex322.htm Edgar Link pending
d892225dex45.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sftwu-20191231.xml Edgar Link completed
sftwu-20191231.xsd Edgar Link pending
sftwu-20191231_cal.xml Edgar Link unprocessable
sftwu-20191231_def.xml Edgar Link unprocessable
sftwu-20191231_lab.xml Edgar Link unprocessable
sftwu-20191231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending